Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02116946
Other study ID # H13-00254
Secondary ID
Status Terminated
Phase Phase 2
First received
Last updated
Start date March 2014
Est. completion date December 2018

Study information

Verified date December 2018
Source University of British Columbia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized controlled clinical trial to investigate the effectiveness, safety and tolerability of platelet-rich plasma (PRP) injections for treatment of patellar tendinopathy in adults 18-50 years of age. Subjects will be randomly assigned to three parallel treatment groups:

1. Leukocyte-rich PRP injection + exercise

2. Leukocyte-poor PRP injection + exercise

3. Saline injection + exercise (control) Primary endpoints are (1) the number (rate) and severity of adverse events as reported by both patients and study physicians during the first 12 weeks after initiation of treatment, (2) patient-rated tolerability of treatment; (3) the change in function (VISA score) and treatment success (global improvement scale) over six months of a post-injection exercise protocol.


Recruitment information / eligibility

Status Terminated
Enrollment 64
Est. completion date December 2018
Est. primary completion date December 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Male or female = 18 and = 50 years of age at Enrollment Visit

- Documentation of a clinical diagnosis of patellar tendinopathy, grade-IIIB Blazina stage, confirmed on ultrasound

- Previously tried an exercise program of at least six weeks duration

- Fluent in official language of study site

- Written informed consent obtained from subject

- Normal values on screening laboratory panels (CBC, PT, PTT, INR, serum creatine, ALT, ALP, AST, bilirubin, albumin)

Exclusion Criteria:

- For women of child-bearing potential, positive pregnancy test at enrollment visit

- Major surgery in the past three months

- Surgery on the symptomatic knee

- Bleeding disorder

- Systemic inflammatory disease

- Arthritis or degenerative knee condition

- Recent fluoroquinolone use

- Subjects who have any requirement for the use of systemic steroids or immunosuppressants

- Subjects who are known to be HIV positive

- Uncooperative patient, or patients who are incapable of following directions or who are predictably unwilling to return for follow-up examinations

- Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Platelet Rich Plasma (PRP)
Injection of Leukocyte-rich or Leukocyte-poor Platelet Rich Plasma prepared by the Angel cPRP System along with a 12 week exercise program for treatment of patients with patellar tendinopathy.
Other:
Saline + exercise
Peritendinous saline injection plus 12 week exercise program.

Locations

Country Name City State
Canada University of Britich Columbia Vancouver British Columbia
Italy Rizzoli Orthopaedic Institute Bologna
Norway Oslo Sports Trauma Research Center Oslo
United States University of Washington Seattle Washington
United States The Steadman Clinic Vail Colorado

Sponsors (7)

Lead Sponsor Collaborator
University of British Columbia American Orthopaedic Society for Sports Medicine, Norwegian Olympic Sports Center, Rizzoli Orthopaedic Institute, Steadman Clinic, University of Oslo, University of Washington

Countries where clinical trial is conducted

United States,  Canada,  Italy,  Norway, 

References & Publications (21)

Bahr R, Fossan B, Løken S, Engebretsen L. Surgical treatment compared with eccentric training for patellar tendinopathy (Jumper's Knee). A randomized, controlled trial. J Bone Joint Surg Am. 2006 Aug;88(8):1689-98. — View Citation

Banfi G, Corsi MM, Volpi P. Could platelet rich plasma have effects on systemic circulating growth factors and cytokine release in orthopaedic applications? Br J Sports Med. 2006 Oct;40(10):816. Epub 2006 Aug 18. — View Citation

Briggs KK, Steadman JR, Hay CJ, Hines SL. Lysholm score and Tegner activity level in individuals with normal knees. Am J Sports Med. 2009 May;37(5):898-901. doi: 10.1177/0363546508330149. Epub 2009 Mar 23. — View Citation

Castillo TN, Pouliot MA, Kim HJ, Dragoo JL. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med. 2011 Feb;39(2):266-71. doi: 10.1177/0363546510387517. Epub 2010 Nov 4. — View Citation

Dragoo JL, Braun HJ, Durham JL, Ridley BA, Odegaard JI, Luong R, Arnoczky SP. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med. 2012 Jun;40(6):1274-81. doi: 10.1177/0363546512442334. Epub 2012 Apr 10. — View Citation

Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J; IMMPACT. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005 Jan;113(1-2):9-19. Review. — View Citation

Engebretsen L, Steffen K, Alsousou J, Anitua E, Bachl N, Devilee R, Everts P, Hamilton B, Huard J, Jenoure P, Kelberine F, Kon E, Maffulli N, Matheson G, Mei-Dan O, Menetrey J, Philippon M, Randelli P, Schamasch P, Schwellnus M, Vernec A, Verrall G. IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med. 2010 Dec;44(15):1072-81. doi: 10.1136/bjsm.2010.079822. — View Citation

Ferretti A. Epidemiology of jumper's knee. Sports Med. 1986 Jul-Aug;3(4):289-95. — View Citation

Filardo G, Kon E, Della Villa S, Vincentelli F, Fornasari PM, Marcacci M. Use of platelet-rich plasma for the treatment of refractory jumper's knee. Int Orthop. 2010 Aug;34(6):909-15. doi: 10.1007/s00264-009-0845-7. Epub 2009 Jul 31. — View Citation

Kon E, Filardo G, Delcogliano M, Presti ML, Russo A, Bondi A, Di Martino A, Cenacchi A, Fornasari PM, Marcacci M. Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee. Injury. 2009 Jun;40(6):598-603. doi: 10.1016/j.injury.2008.11.026. Epub 2009 Apr 19. — View Citation

Kongsgaard M, Kovanen V, Aagaard P, Doessing S, Hansen P, Laursen AH, Kaldau NC, Kjaer M, Magnusson SP. Corticosteroid injections, eccentric decline squat training and heavy slow resistance training in patellar tendinopathy. Scand J Med Sci Sports. 2009 Dec;19(6):790-802. doi: 10.1111/j.1600-0838.2009.00949.x. Epub 2009 May 28. — View Citation

Kongsgaard M, Qvortrup K, Larsen J, Aagaard P, Doessing S, Hansen P, Kjaer M, Magnusson SP. Fibril morphology and tendon mechanical properties in patellar tendinopathy: effects of heavy slow resistance training. Am J Sports Med. 2010 Apr;38(4):749-56. doi: 10.1177/0363546509350915. Epub 2010 Feb 12. — View Citation

Larsson ME, Käll I, Nilsson-Helander K. Treatment of patellar tendinopathy--a systematic review of randomized controlled trials. Knee Surg Sports Traumatol Arthrosc. 2012 Aug;20(8):1632-46. doi: 10.1007/s00167-011-1825-1. Epub 2011 Dec 21. Review. — View Citation

Lian O, Engebretsen L, Ovrebø RV, Bahr R. Characteristics of the leg extensors in male volleyball players with jumper's knee. Am J Sports Med. 1996 May-Jun;24(3):380-5. — View Citation

Lian OB, Engebretsen L, Bahr R. Prevalence of jumper's knee among elite athletes from different sports: a cross-sectional study. Am J Sports Med. 2005 Apr;33(4):561-7. Epub 2005 Feb 8. — View Citation

Rees JD, Maffulli N, Cook J. Management of tendinopathy. Am J Sports Med. 2009 Sep;37(9):1855-67. doi: 10.1177/0363546508324283. Epub 2009 Feb 2. — View Citation

Scott, A, KM Khan, J Cook, and V Duronio, Human tendon overuse pathology: histopathologic and biochemical findings, in Tendinopathy in Athletes, S.L. Woo, S.P. Arnoczky, and P. Renstrom, Editors. 2007, Blackwell Publishing Ltd: Malden, Massachusetts. p. 69-84.

Sheth U, Simunovic N, Klein G, Fu F, Einhorn TA, Schemitsch E, Ayeni OR, Bhandari M. Efficacy of autologous platelet-rich plasma use for orthopaedic indications: a meta-analysis. J Bone Joint Surg Am. 2012 Feb 15;94(4):298-307. doi: 10.2106/JBJS.K.00154. Review. — View Citation

Thanasas C, Papadimitriou G, Charalambidis C, Paraskevopoulos I, Papanikolaou A. Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. Am J Sports Med. 2011 Oct;39(10):2130-4. doi: 10.1177/0363546511417113. Epub 2011 Aug 2. — View Citation

van Ark M, Zwerver J, van den Akker-Scheek I. Injection treatments for patellar tendinopathy. Br J Sports Med. 2011 Oct;45(13):1068-76. doi: 10.1136/bjsm.2010.078824. Epub 2011 May 3. Review. — View Citation

Warden SJ, Metcalf BR, Kiss ZS, Cook JL, Purdam CR, Bennell KL, Crossley KM. Low-intensity pulsed ultrasound for chronic patellar tendinopathy: a randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford). 2008 Apr;47(4):467-71. doi: 10.1093/rheumatology/kem384. Epub 2008 Feb 12. — View Citation

* Note: There are 21 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical Efficacy Number and frequency of adverse events will be assessed/reported weekly for the first 12 weeks and at the 6 month visit. 2 years
Secondary Change in function over time measured by VISA Score To compare change in function (VISA score) between participants randomized to the three treatment groups over six months, 1 year, and 2 years of a post-injection exercise protocol. 2 years
Secondary Comparison of treatment success measured by Likert Global Improvement Scale To compare change in treatment success (Likert global improvement scale) between participants randomized to the three treatment groups over six months, 1 year, and 2 years of a post-injection exercise protocol. 2 years
Secondary Change in activity levels over time measured by Tegner Activity Score To compare change in activity levels (Tegner Activity Score) between participants randomized to the three groups over six months, 1 year, and 2 years of an exercise protocol. 2 years
Secondary Change in activity-related pain over time measured by Pain Numeric Rating Scale To compare change in activity-related pain (Pain Numeric Rating Scale) between participants randomized to the three groups over six months, 1 year, and 2 years of an exercise protocol. 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT04640337 - Influence of Placebo on Intratissue Percutaneous Electrolysis in Patellar Tendinopathy N/A
Recruiting NCT06056440 - Efficacy of a Physical Rehabilitation Program Using Virtual Reality in Patients With Chronic Tendinopathy (Virtendon-Rehab) N/A
Recruiting NCT06381492 - Quantifying Patellar Tendon Microstructure Using DTI
Enrolling by invitation NCT06102421 - Evaluation of the Effectiveness of Extracorporeal Shockwave Therapy in Patients With Patellar Tendinopathy on Its Micromorphology
Completed NCT03096067 - Patellar Tendinopathy - The Effect of Load Magnitude in Exercise-based Treatment N/A
Recruiting NCT05731037 - Influence of Restitution Time in Treatment of Patellar Tendinopathy N/A
Completed NCT03694730 - Continued Activity During Rehabilitation in Patients With Patellar Tendinopathy N/A
Completed NCT01111773 - Study Evaluating a Heated Lidocaine and Tetracaine Topical Patch in the Treatment of Patients With Patellar Tendinopathy Phase 2
Active, not recruiting NCT04753853 - Stromal Vascular Fraction (SVF) Injection in the Treatment of Patellar Tendinopathy N/A
Terminated NCT03196063 - Effectiveness of Two Exercise Protocols in the Treatment of Patients With Patellar Tendinopathy N/A
Completed NCT01460004 - The Effect of Infrapatellar Strap Treatment on Pain Extent and Athletic Measures in Young Athletes N/A
Completed NCT04650997 - The Mechanical,Physiological and Therapeutic Effects of Eccentric Exercise Combined With Extracorporeal Shockwave Therapy in Athletes With Patellar Tendinopathy N/A
Not yet recruiting NCT04204460 - Electromyographic Evaluation of Quadriceps During Eccentric Decline Squat
Active, not recruiting NCT03454737 - Treatment of Refractory Patellar Tendinopathy With Mesenquimal Trunk Cells. Comparative Study With PRP. N/A
Completed NCT06199583 - Diagnostic Value of Shear-Wave Elastography for Patellar Tendinopathy
Active, not recruiting NCT04550013 - Blood Flow Restriction Training for Treatment of Chronic Patellar Tendinopathy N/A
Recruiting NCT05407194 - Effect of Collagen/Vitamin C in Jumper's Knee; a RCT N/A